RA specifically bound to TDP‐43 and induced its mitochondria localization and mtDNA release, leading to cGAS/STING‐dependent activation of NF‐κB and type I IFN signaling, thereby reprogrammed TME and sensitized tumor response to anti‐PD1 antibody treatment. The gene discussed is STING1; the disease is neoplasm.